TGCT in the Youngest Patients

Tenosynovial giant cell tumor (TGCT) predominantly impacts young individuals, 20-50 years of age. While less common, TGCT can impact children. Children impacted by TGCT have unique challenges associated with their immature skeletal structures and chronic nature of the disease. Finding a pediatric specialists in TGCT may be difficult. It is of the utmost importance to preserve the health of childrens' joints and provide options for their care and management of TGCT.
Understanding these difficulties, TGCT Support is hosting a webinar with Drs Ajay Gupta and Thomas Scharschmidt to facilitate knowledge in this ultra-rare population. Dr Gupta will cover potential systemic therapies available for pediatric patients and the uncertainties involved in care. Dr Scharschmidt will cover surgical management and key considerations in the management of TGCT in pediatrics.